A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914
NCT01929629
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Gonococcal (GC) Infection
Interventions
DRUG:
Part A
DRUG:
Part B
Sponsor
AstraZeneca